US Patent Issued to NEUROVENTI on Aug. 26 for "Composition comprising rilmenidine compound as active ingredient for treatment of fragile X syndrome or related developmental disability" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 26 -- United States Patent no. 12,396,983, issued on Aug. 26, was assigned to NEUROVENTI (Seoul, South Korea).

"Composition comprising rilmenidine compound as active ingredient for treatment of fragile X syndrome or related developmental disability" was invented by Sohyun Joo (Seoul, South Korea), Chanyoung Shin (Seoul, South Korea), Sejin Jeon (Seoul, South Korea) and Taejin Ahn (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a composition for preventing, improving, or treating fragile X syndrome, fragile X syndrome-related developmental disorders, autism spectrum disorder or schizophrenia, comprising rilmenidine, a rilmenidine metabo...